[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334546-105":59,"doc-detail-334546-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","synergistic-anticancer-activity-of-plumbagin-and-xanthohumol-combination-on-pancreatic-cancer-models","Synergistic Anticancer Activity of Plumbagin and Xanthohumol Combination on Pancreatic Cancer Models","","Pancreatic cancer is an especially aggressive disease with limited diagnostic options and persistent chemoresistance. This work evaluates whether combining the natural compounds plumbagin and xanthohumol produces stronger anticancer effects than single agents, and clarifies the mechanism involved. The study tests multiple plant-derived extracts in vitro and selects an effective combination for in vivo assessment using the transgenic KPC pancreatic cancer model. Synergy is observed across pancreatic cancer cell lines. The combination modulates BCL2 levels linked to apoptosis in both cells and tissues, and significantly increases survival in treated KPC mice, supporting a potential new therapeutic approach.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/synergistic-anticancer-activity-of-plumbagin-and-xanthohumol-combination-on-pancreatic-cancer-models/334546/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/synergistic-anticancer-activity-of-plumbagin-and-xanthohumol-combination-on-pancreatic-cancer-models/334546.png","ImageObject",300,407,{"name":92,"@type":93},"Patrick","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is combination chemotherapy needed for pancreatic cancer?","Question",{"text":112,"@type":113},"Pancreatic cancer has poor prognosis and high chemoresistance, limiting the effectiveness of available treatments. The study motivates combination options to overcome resistance and improve outcomes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What anticancer effects does the plumbagin and xanthohumol combination show?",{"text":117,"@type":113},"The combination demonstrates significant synergistic anticancer activity in vitro across different pancreatic cancer cell lines and improves survival in a transgenic KPC mouse model.",{"name":119,"@type":110,"acceptedAnswer":120},"How does the combination influence the proposed mechanism?",{"text":121,"@type":113},"Treatment alters BCL2 levels, a factor associated with apoptosis. The effect is confirmed in both cell lysates and tissues, and supports the mechanistic link to apoptosis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334546,1790260078,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","Article  \nSynergistic Anticancer Activity of Plumbagin and Xanthohumol Combination on Pancreatic Cancer Models  \nRanjith Palanisamy 1, Nimnaka Indrajith Kahingalage 1, David Archibald 2, Ilaria Casari 1 and Marco Falasca 1,3, *  \nCitation: Palanisamy, R.; Indrajith Kahingalage, N.; Archibald, D.; Casari, I.; Falasca, M. Synergistic Anticancer Activity of Plumbagin and Xanthohumol Combination on Pancreatic Cancer Models. Int. J. Mol. Sci. 2024, 25, 2340. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/ijms25042340](10.3390/ijms25042340)  \nAcademic Editors: Claudio Luchini and Donatella Delle Cave  \nReceived: 23 January 2024  \nRevised: 12 February 2024  \nAccepted: 12 February 2024  \nPublished: 16 February 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Metabolic Signalling Group, Curtin Medical School, Curtin Health Innovation Research Institute, Curtin University, Perth 6102, Australia; [ranjith.palanisamy@telethonkids.org.au](ranjith.palanisamy@telethonkids.org.au) (R.P.); [indrajithnimnaka7@gmail.com](indrajithnimnaka7@gmail.com) (N.I.K.); [ilacasari@gmail.com](ilacasari@gmail.com) (I.C.)  \n2 Backreef Oil Pty Ltd., Perth 6015, Australia; [david.archibald@westnet.com.au](david.archibald@westnet.com.au)  \n3 Department of Medicine and Surgery, University of Parma, Via Volturno 39, 43125 Parma, Italy  \n* [Correspondence: marco.falasca@unipr.it](Correspondence: marco.falasca@unipr.it)  \nAbstract: Among diverse cancers, pancreatic cancer is one of the most aggressive types due to inadequate diagnostic options and treatments available. Therefore, there is a necessity to use combination chemotherapy options to overcome the chemoresistance of pancreatic cancer cells. Plumbagin and xanthohumol, natural compounds isolated from the Plumbaginaceae family and Humulus lupulus, respectively, have been used to treat various cancers. In this study, we investigated the anticancer effects of a combination of plumbagin and xanthohumol on pancreatic cancer models, as well as the underlying mechanism. We have screened in vitro numerous plant-derived extracts and compounds and tested in vivo the most effective combination, plumbagin and xanthohumol, using a transgenic model of pancreatic cancer KPC (KrasLSL.G12D/+; p53R172H/+; PdxCretg/+) . A significant synergistic anticancer activity of plumbagin and xanthohumol combinations on different pancreatic cancer cell lines was found. The combination treatment of plumbagin and xanthohumol influences the levels of B-cell lymphoma (BCL2), which are known to be associated with apoptosis in both cell lysates and tissues. More importantly, the survival of a transgenic mouse model of pancreatic cancer KPC treated with a combination of plumbagin and xanthohumol was significantly increased, and the effect on BCL2 levels has been confirmed. These results provide a foundation for a potential new treatment for pancreatic cancer based on plumbagin and xanthohumol combinations.  \nKeywords: pancreatic cancer; plumbagin; xanthohumol; drug combinations; phytochemicals  \n1. Introduction  \nPancreatic cancer (PC) is one of the most hostile and intractable types of cancer in the world with an incidence-to-mortality ratio of close to one. It has an extremely poor prognosis resulting in a five-year survival rate of approximately 12%[1,2] . Pancreatic cancer is estimated to become the second most common cause of cancer-related death in 2040 [3] . Surgery is the only possible treatment for primary-stage or resectable pancreatic tumours [4] and, even in this case, cancer relapses and metastasis development are a major concern [5] . Presently, chemotherapy is the only feasible option available to i","cbCaioaWarp6aZir","https://ap.wps.com/l/cbCaioaWarp6aZir","pdf",3703846,14,"English","# Abstract\n# Keywords\n# Introduction","[{\"question\":\"Why is combination chemotherapy needed for pancreatic cancer?\",\"answer\":\"Pancreatic cancer has poor prognosis and high chemoresistance, limiting the effectiveness of available treatments. The study motivates combination options to overcome resistance and improve outcomes.\"},{\"question\":\"What anticancer effects does the plumbagin and xanthohumol combination show?\",\"answer\":\"The combination demonstrates significant synergistic anticancer activity in vitro across different pancreatic cancer cell lines and improves survival in a transgenic KPC mouse model.\"},{\"question\":\"How does the combination influence the proposed mechanism?\",\"answer\":\"Treatment alters BCL2 levels, a factor associated with apoptosis. The effect is confirmed in both cell lysates and tissues, and supports the mechanistic link to apoptosis.\"}]","Synergistic Anticancer Activity of Plumbagin and Xanthohumol Combination on Pancreatic Cancer Models | PDF",1790007138,35]